Published in AIDS Weekly, April 16th, 2001
S.P. Sweet and colleagues at Guy's Hospital compared calprotectin levels in HIV and Sjogren's syndrome patients, who often suffer from oral candidiasis, with levels in patients who contracted this fungal infection through other oral disorders.
Sweet et al. found that HIV patients, unlike other oral candidiasis sufferers, have reduced oral calprotectin levels which might affect the course of candidiasis infection.
All oral candidiasis sufferers other than HIV patients...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2001-04-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.